No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Actuate Therapeutics Inc - Statistical Significance Met on Primary Endpoints in Phase 2 Trial
Express News | Actuate Therapeutics Inc - Elraglusib in Combination With Gnp Shows Favorable Risk-Benefit Profile
Express News | Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Express News | Actuate Therapeutics to Be Added to Russell 2000® Index
Actuate Therapeutics to Be Added to Russell 2000 Index
Unlock the Full List